Rho Capital Partners 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
ANACOR PHARMACEUTICALS INC	COM	032420101	26,131	1,067,892	SH		SOLE		1,067,892	0	0
CARA THERAPEUTICS INC	COM	140755109	22,385	2,668,057	SH		SOLE		2,668,057	0	0
EVERYDAY HEALTH INC	COM	300415106	82,541	5,908,432	SH		SOLE		5,908,432	0	0
INTRALINKS HLDGS INC	COM	46118H104	52,573	6,490,503	SH		SOLE		6,490,503	0	0
NEPHROGENEX INC	COM	640667101	6,210	1,326,826	SH		SOLE		1,326,826	0	0
REACHLOCAL INC	COM	75525F104	9,279	2,570,395	SH		SOLE		2,570,395	0	0